NCT01302392 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 158
- group Id
- BG001
- value
- 157
- group Id
- BG002
- value
- 315
- units
- Participants
- groups
- description
- Best Supportive Care: Corticosteroid (either prednisolone 30 mg orally (PO) every other day, dexamethasone 6 mg PO every other day, or other equivalent corticosteroid). Optional cyclophosphamide 50 mg PO once daily may be given at the Investigator's discretion (maximum of 1400 mg per 28-day cycle).
- id
- BG000
- title
- Best Supportive Care
- description
- Carfilzomib: 20mg/m² IV on Days 1 and 2 of Cycle 1, escalating to 27 mg/m² IV on Days 8,9,15,and 16 of Cycle 1 and continuing on Days 1,2,8,9,15,and 16 of Cycles 2 through Cycle 9. Cycles 10 and beyond will receive 27 mg/m² IV on Days 1,2,15, and 16 (alternatively, the investigator could choose to continue the dosing frequency on the original dosing days \[Days 1, 2, 8, 9, 15, 16\] for individual subjects).
- id
- BG001
- title
- Carfilzomib
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.02
- value
- 65.5
- group Id
- BG001
- spread
- 10.71
- value
- 63.3
- group Id
- BG002
- spread
- 9.50
- value
- 64.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 75
- group Id
- BG002
- value
- 137
- title
- Female
- measurements
- group Id
- BG000
- value
- 96
- group Id
- BG001
- value
- 82
- group Id
- BG002
- value
- 178
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 5
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 148
- group Id
- BG001
- value
- 151
- group Id
- BG002
- value
- 299
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 9
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 138
- group Id
- BG001
- value
- 140
- group Id
- BG002
- value
- 278
- title
- Europe
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 37
- title
- Non-Europe
- param Type
- NUMBER
- title
- Region
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 36
- title
- 3
- categories
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 69
- title
- 4
- categories
- measurements
- group Id
- BG000
- value
- 104
- group Id
- BG001
- value
- 106
- group Id
- BG002
- value
- 210
- title
- ≥5
- param Type
- NUMBER
- title
- Number of Prior Regimens to Treat Multiple Myeloma
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 158
- group Id
- BG001
- value
- 157
- group Id
- BG002
- value
- 315
- units
- Participants
- groups
- description
- Best Supportive Care: Corticosteroid (either prednisolone 30 mg orally (PO) every other day, dexamethasone 6 mg PO every other day, or other equivalent corticosteroid). Optional cyclophosphamide 50 mg PO once daily may be given at the Investigator's discretion (maximum of 1400 mg per 28-day cycle).
- id
- BG000
- title
- Best Supportive Care
- description
- Carfilzomib: 20mg/m² IV on Days 1 and 2 of Cycle 1, escalating to 27 mg/m² IV on Days 8,9,15,and 16 of Cycle 1 and continuing on Days 1,2,8,9,15,and 16 of Cycles 2 through Cycle 9. Cycles 10 and beyond will receive 27 mg/m² IV on Days 1,2,15, and 16 (alternatively, the investigator could choose to continue the dosing frequency on the original dosing days \[Days 1, 2, 8, 9, 15, 16\] for individual subjects).
- id
- BG001
- title
- Carfilzomib
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.02
- value
- 65.5
- group Id
- BG001
- spread
- 10.71
- value
- 63.3
- group Id
- BG002
- spread
- 9.50
- value
- 64.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 75
- group Id
- BG002
- value
- 137
- title
- Female
- measurements
- group Id
- BG000
- value
- 96
- group Id
- BG001
- value
- 82
- group Id
- BG002
- value
- 178
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 5
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 148
- group Id
- BG001
- value
- 151
- group Id
- BG002
- value
- 299
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 9
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 138
- group Id
- BG001
- value
- 140
- group Id
- BG002
- value
- 278
- title
- Europe
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 37
- title
- Non-Europe
- param Type
- NUMBER
- title
- Region
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 36
- title
- 3
- categories
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 69
- title
- 4
- categories
- measurements
- group Id
- BG000
- value
- 104
- group Id
- BG001
- value
- 106
- group Id
- BG002
- value
- 210
- title
- ≥5
- param Type
- NUMBER
- title
- Number of Prior Regimens to Treat Multiple Myeloma
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle